India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market.

Power Grid, Gland Pharma, Lupin, Godrej Properties, Garden Reach, JK Tyres, DOMS Industries, Castrol India and more will be ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

Tax experts have indicated that about a third of the tax relief, estimated at Rs 1 lakh crore, could go into consumer ...